Zhu Lei, Hoffmann Angelika, Wintermark Max, Pan Xianmang, Tu Richard, Rapp Joseph H
Vascular Surgery Service, San Francisco Department of Veterans Affairs Medical Center, San Francisco, California 94121, USA.
J Surg Res. 2012 Aug;176(2):679-83. doi: 10.1016/j.jss.2011.09.059. Epub 2011 Oct 25.
As they are "end arteries," microembolic obstruction of brain penetrating arteries would be expected to create ischemia. Yet the mammalian brain appears to have an impressive tolerance to experimental microembolization with ischemia occurring only after the injection of large numbers of particulates. Potential explanations could be that the majority of these particulates marginate along the pial vasculature or escape the cerebral circulation via arteriovenous (AV) fistulae.
To test these theories, we first established the level of injury created by the injection of 20, 45, and 90 μm fluorescent microspheres in Sprague-Dawley rats. Brains were examined by immunohistochemistry for injury and for infarction. We then injected 1000 size 20 μm, 500 size 45 μm, and 150 size 90 μm and harvested the brains and lungs for assays of fluorescence. The location of microemboli within the brain was established by determining the percent of 20 and 45 μm fluorescent microspheres entering the superficial versus deeper layers of the brain. The location of larger microemboli was established by 2T-MRI after injection of 60-100 μm microthrombi labeled with supraparamagnetic iron oxide (SPIO) particles.
With 20 μm microspheres there were no areas of injury or infarction after injection of 500 and rare areas of injury and no infarctions after injection of 1000 microspheres. With either 250 or 500 size 45 μm microspheres there were a few (≤ 6) small areas of injury per animal with ≤ 2 areas of infarction. After injection, 93%-96% of injected microspheres remained in the brain. Approximately 40% of either fluorescent or SPIO labeled microthrombi were found on the brain surface.
As in humans, the rat brain has an impressive tolerance to microemboli, although this clearly varies with emboli size and number. Wash out of particulates through AV connections is not a major factor in brain tolerance in this model. Approximately 40% of microemboli remain in the larger pial vasculature where the more extensive collateralization may limit their effects on distal perfusion. However, the remaining 60% enter penetrating arteries but few create ischemia.
由于脑穿通动脉是“终末动脉”,预计其微栓塞会导致缺血。然而,哺乳动物的大脑似乎对实验性微栓塞具有惊人的耐受性,只有在注射大量微粒后才会发生缺血。可能的解释是,这些微粒中的大多数沿软脑膜血管边缘化,或通过动静脉(AV)瘘逃离脑循环。
为了验证这些理论,我们首先确定了在Sprague-Dawley大鼠中注射20、45和90μm荧光微球所造成的损伤程度。通过免疫组织化学检查大脑的损伤和梗死情况。然后我们注射1000个20μm的、500个45μm的和150个90μm的微球,并采集大脑和肺进行荧光检测。通过确定进入大脑浅层和深层的20μm和45μm荧光微球的百分比来确定脑内微栓子的位置。在注射用超顺磁性氧化铁(SPIO)颗粒标记的60 - 100μm微血栓后,通过2T - MRI确定较大微栓子的位置。
注射20μm微球时,注射500个后没有损伤或梗死区域,注射1000个后有罕见的损伤区域且无梗死。注射250个或500个45μm微球时,每只动物有少数(≤6个)小面积损伤区域,梗死区域≤2个。注射后,93% - 96%的注射微球留在大脑中。约40%的荧光或SPIO标记的微血栓位于脑表面。
与人类一样,大鼠大脑对微栓子具有惊人的耐受性,尽管这显然因栓子大小和数量而异。在该模型中,通过AV连接清除微粒不是大脑耐受性的主要因素。约40%的微栓子留在较大的软脑膜血管中,那里更广泛的侧支循环可能会限制它们对远端灌注的影响。然而,其余60%进入穿通动脉,但很少导致缺血。